MISSION, Kan. – After more than a year of fretting over her 13-year son with a rare liver disease, Heather Ousley broke into tears when she learned that he and millions of other youngsters could soon be eligible for the COVID-19 vaccine.
“This day is the best day in the history of days!!! I love this day!!!” she texted, joining other parents and educators in welcoming the news that the Food and Drug Administration is expected to authorize Pfizer’s vaccine by next week for children ages 12 to 15.
Ousley, president of the school board for the 27,000-student Shawnee Mission School District in Kansas, plans to get her 13- and 15-year-olds promptly vaccinated and then celebrate with ice cream. They have been learning from home with their younger brother since the start of the outbreak.
Pfizer is also anticipating the FDA will endorse use of its vaccine in even younger children sometime this fall. And results are expected by the middle of this year from a U.S. study of Moderna’s shots in 12- to 17-year-olds.
Officials are hoping that extending vaccinations to children will drive down the nation's caseload even further and allow schools to reopen with minimal disruption this fall.
It could also reassure parents and teachers alike. While children rarely get seriously ill from the coronavirus, then can still get sick and spread it to others.
Pfizer in March released preliminary results from a study of 2,260 U.S. volunteers ages 12 to 15, showing there were no cases of COVID-19 among fully vaccinated children compared with 18 among those given dummy shots.
That is welcome news for Robin and Aaron Perry of Sun Prairie, Wisconsin, who have five boys, ages 5 to 17. Their oldest, Cooper, has been battling leukemia and contracted COVID-19 in November, in what his mother described as a “terrifying” time for the family. The disease spread to the rest of the family.